Personalized Medicine Scientist

McKesson Corporation
United States, Tennessee, Nashville
May 02, 2025
It's More Than a Career, It's a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world. The Personalized Medicine Scientist will serve as the primary scientific resource enabling SCRI's Personalized Medicine program. The Personalized Medicine Scientist will act as a scientific consultant to enable one of two primary programmatic functions: 1) SCRI's Personalized Medicine operations strategy or 2) SCRI's Personalized Medicine population sciences strategy. In either function, the Personalized Medicine Scientist will be required to assimilate clinical, molecular, and clinical trial data to help support SCRI's Personalized Medicine strategies which include molecular cancer conferences and other educational activities, collaborating with personalized medicine staff to build presentations that will be presented to physician leaders, investigators, and research staff, and tracking program metrics. The Scientist will develop and maintain a knowledgebase of clinically actionable oncology-specific mutations and matched targeted therapies, immunotherapies, and clinical trials. The Personalized Medicine Scientist will act as a consultant to oversee scientific aspects of the Personalized Medicine program and will interact with investigators, study sponsors, research colleagues, and other healthcare providers. Duties include and are not limited to: Prepare, schedule, and help facilitate Molecular Tumor Boards and molecular education seminars for multiple facilities at SCRI Strategic Sites Analyze patient molecular profiles to identify potential targeted therapies, clinical trials, or contraindications Interact independently with medical oncologists, research staff, and care teams to assist in interpreting molecular profiling results Assist in the identification of patients for both molecularly-targeted and non-molecularly-targeted clinical trials and coordinate with research sites for screening Develop and foster relationships with physicians and research staff in order to provide scientific advice to advance Personalized Medicine Capture metrics for ongoing Personalized Medicine efforts including molecular profiles ordered and Molecular Tumor Board outcomes Track the total number of patients reviewed at molecular tumor boards, data inquiries requested, and average time for patient case review. Report metrics monthly to leadership. Qualifications needed: Master's Degree required, PhD preferred 1+ year work experience and a working understanding of cell biology and cell signaling pathways Must have a working knowledge of oncology-specific therapeutics and mechanisms of action Must have an understanding of cancer genomics and sequencing technologies Must have an understanding of clinical and records-based research process Education may be substituted for partial experience This position will sit in Nashville, TN. You must currently reside in the Greater Nashville Area or be open to relocating. About Sarah Cannon Research Institute Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI's research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings. We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That's why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here. As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered. We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.